These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6115741)

  • 1. Psychotic exacerbation with haloperidol.
    Tornatore FL; Lee D; Sramek JJ
    Drug Intell Clin Pharm; 1981 Mar; 15(3):209-13. PubMed ID: 6115741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
    Sachdev P; Tang WM
    Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound psychoses following the discontinuation of a high potency neuroleptic.
    Kahne GJ
    Can J Psychiatry; 1989 Apr; 34(3):227-9. PubMed ID: 2720555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of haloperidol neurotoxicity in acute hyperthyroidism: report of a case.
    Chu H; Lin JC; Hsu YD
    Acta Neurol Taiwan; 2004 Sep; 13(3):126-30. PubMed ID: 15508939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible neurotoxicity with combined lithium-haloperidol administration.
    Keitner GI; Rahman S
    J Clin Psychopharmacol; 1984 Apr; 4(2):104-5. PubMed ID: 6423702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotic patients who become worse on neuroleptics.
    Bowers MB; Swigar ME
    J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabergoline-induced psychotic exacerbation in schizophrenic patients.
    Chang SC; Chen CH; Lu ML
    Gen Hosp Psychiatry; 2008; 30(4):378-80. PubMed ID: 18585544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced dysphagia: case report and literature review.
    Dziewas R; Warnecke T; Schnabel M; Ritter M; Nabavi DG; Schilling M; Ringelstein EB; Reker T
    Dysphagia; 2007 Jan; 22(1):63-7. PubMed ID: 17024549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of schizophrenic psychoses with haloperidol and valproate.
    Dose M; Hellweg R; Yassouridis A; Theison M; Emrich HM
    Pharmacopsychiatry; 1998 Jul; 31(4):122-5. PubMed ID: 9754845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the optimal dose of haloperidol in first-episode psychosis.
    Oosthuizen P; Emsley RA; Turner J; Keyter N
    J Psychopharmacol; 2001 Dec; 15(4):251-5. PubMed ID: 11769818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
    Krakowski M; Czobor P; Volavka J
    Psychiatry Res; 1997 Jun; 71(1):19-26. PubMed ID: 9247978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 17. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
    Granacher RP; Baldessarini RJ
    Arch Gen Psychiatry; 1975 Mar; 32(3):375-80. PubMed ID: 1115577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of psychosis by tricyclic antidepressants in delusional depression.
    Nelson JC; Bowers MB; Sweeney DR
    Am J Psychiatry; 1979 Apr; 136(4B):574-6. PubMed ID: 426146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.